Serum NGAL concentrations are higher in patients with decreased kidney function than in healthy controls; however, there is debate over the variations in serum NGAL levels between patients with acute kidney injury (AKI) and those with CKD. The gene discussed is LCN2; the disease is chronic kidney disease.